
After decades of discussions, the agency advances its agenda aiming to create a genetic bank of the plant in Brazil

A new perspective on symptom management and quality of life

Uruguayan company offers complete solutions for high-quality CBD products

Judge Vera Lúcia Feil's injunction orders the release of the company's cannabidiol after facing automatic denials from the regulatory agency

Data released by Infarmed considers the period since 2019. Growth was 1200%

Understand the therapeutic benefits of cannabis and the importance of medical knowledge

Working Group and Regulation to be formed in 30 days to facilitate access to products based on the plant

The Brazilian Association of Cannabinoid Industry (BRcann) forum brought together sector representatives and Anvisa to discuss regulatory updates, research, information, and market

“There are about 4000 valid HCs currently,” says lawyer Emílio Figueiredo as he explores the benefits and challenges of patients' journey towards therapeutic autonomy.

Cases in Jamaica and Paraguay reinforce the need for regulation and awareness

The councilors unanimously approved the Bill in the first vote; the text defines the use of plant derivatives for therapeutic purposes

The pioneering initiative is educational in nature and aims to raise awareness among different police officers and other public officials of institutions dealing with medicinal cannabis in Brazil through current regulations

Court relied on Anvisa resolution to justify favorable opinion

After the approval of the bylaws, the objective now is to promote debates aimed at establishing a policy for palliative treatment of various diseases through medicinal cannabis

The decision from the 16th Federal Court ends the prohibition of flowers and mandates the release of THC and CBD-based products as active ingredients.

This Tuesday's live event (22) features experts discussing the importance of medical training in cannabinoid therapy

Special edition gathers experts to discuss marijuana, its legal status, and impact on communities

Court authorization paves the way for personalized and more accessible products for the population

In a live session, the president of the Latin American Industrial Hemp Association (LAIHA) states that the pre-defined limit of 0.3% THC does not mean that hemp is not cannabis.

The plant is considered a viable alternative treatment in Southeast Asia